Singapore: Australian company Bionomics has made public new data on BNC375, its drug candidate with potential for the tr...
Singapore: Australia's Allied Healthcare Group has successfully completed an oversubscribed strategic placement which ra...
Singapore: Australian therapeutic goods administration (TGA) has approved Aubagio (teriflunomide) 14 mg as a new once-da...
Singapore: ASX-listed Living Cell Technologies has appointed Dr Andrea Grant to the board as managing director. Mr Roy A...
Singapore: Alchemia's commercialization partner Dr Reddy's Laboratories has launched Alchemia's FDA approved generic an...
Bangalore: Australian drug delivery technology company Phosphagenics has licensed an injectable antibiotic product, har...
Singapore: Bionomics presented an update on its renal cancer candidate's (BNC105) clinical trial program at the annual A...
Contrast induced nephropathy (CIN) is a form of kidney damage caused by the toxic effects of dyes (contrast) used by car...
Singapore: Prana Biotechnology, listed with the ASX, has reported progress in the phase II clinical trials with its lead...
Singapore: A team of cancer scientists from The University of Western Australia (UWA) have found that the gene known to ...
Singapore: The US has been making several modifications to its patent laws lately and this is impacting the global biote...
Singapore: Australia-based medical technology company iSonea has completed testing and technical documentation for the A...
Singapore: Australia-based Bionomics' CEO, Dr Deborah Rathjen, has provided an update about the company at the Biotech...
‎Singapore: Supply chain firm, Marken has appointed Mr Michael Culme-Seymour as VP, Asia Pacific, effective Octobe...
Singapore: Silence Therapeutics, a leading RNA interference (RNAi) therapeutics company based in the UK, has signed an a...
Singapore: Allied Healthcare has announced that its Herpes Simplex Virus (HSV-2) vaccine has received ethical approval t...
Singapore: UniQuest has partnered with US-based Emory University to package biotech assets for a new start-up company fr...
Singapore: The director and CEO of Australia's largest virology and communicable disease research center, Burnet Institu...
Singapore: Australian infectious disease therapy and vaccine development company BioDiem's novel antimicrobial (BDM-I) w...
Singapore: The Board of Medicines Australia has announced that Dr Martin Cross has been appointed as the new chair of Me...
Singapore: University of Queensland (UQ) is soon going to globally launch a delicious berry-like ancient Chinese red bay...
Singapore: Two months after Leicestershire company Nova Laboratories received US approval to sell Xaluprine in the count...
Singapore: Fisher & Paykel Healthcare has appointed Mr Donal O'Dwyer as an additional non-executive director of the...
Singapore: Australia's Osprey Medical has enrolled the first patient in Cincor IDE clinical study at the Leipzig Heart C...
Singapore: Mr Chris Fullerton, chairman of Australian firm Bionomics, will retire from the board of Bionomics, effective...
Singapore: Agenix has entered an agreement with Tyrian Diagnostics to license its rapid point-of-care human diagnostic ...
Singapore: Australia-based QRxPharma is proceeding with US FDA to discuss the company's Moxduo new drug application (NDA...
Singapore: According to a latest study published online in Neurology, omega-3 fatty acids, like those found in Omega XL ...
Singapore: Agilent Technologies extended its collaboration with the University of Sydney, Australia, by providing advanc...
Singapore: PolyActiva raised $9.53 million (AUD $9.2 million) in a Series B financing round from a consortium of investo...
Singapore: ElectroCore's GammaCore therapy has been approved for commercial sale by the Therapeutic Goods Administratio...
Singapore: Sigma Pharmaceuticals has agreed to sell its over-the-counter and pharmaceutical divisions to Aspen Global. U...
Singapore: In a release issued last week, the peak body concerned with the disease warned that Australia already has an ...
Singapore: GSK is working with the Therapeutic Goods Administration (TGA) to voluntarily recall for quality reasons six...
Singapore: At the AIDS 2014 Conference in Melbourne, Australia, scientists declared that they had identified a biomarker...
Singapore: Patrys released additional data from the first cohort of multiple myeloma patients treated with PAT-SM6 in th...
Singapore: Australian company Linear Clinical Research has won the Emerging Exporter of the year Award at the 50th annua...
Singapore: Clinuvel Pharmaceuticals commenced its confirmatory phase III clinical trial of its novel drug SCENESSE (afam...
Phylogica, a leading peptide drug discovery company based in Australia, has developed a world-class drug discovery platf...
Singapore: Specialty pharmaceutical company Hatchtech successfully completed end-of-phase II (EOP2) consultations with t...
Singapore: Senz Oncology announced that the ï¬rst patient has commenced treatment in a phase I/II clinical evaluati...
Singapore: Resverlogix has initiated an exploratory phase II clinical trial in patients with pre-diabetes mellitus to e...
Life Sciences Queensland (LSQ), Australia, offers opportunity for industry stakeholders to come together and cooperate t...
Singapore: The GBI Research has revealed that the non-small cell lung cancer (NSCLC) therapeutics market value in the As...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: Brisbane-based pharma firm Alchemia has appointed Mr Charles (Charlie) Walker as its chief executive officer....
Singapore: Patrys, an Australian clinical stage biopharmaceutical company, has completed the initial treatment of the fi...
Singapore: Associate Professor Tiziano Barberi and Dr Isabella Mengarelli from the Australian Regenerative Medicine Inst...
Singapore: US-based Echo Therapeutics, a company developing its needle-free Symphony tCGM System as a non-invasive, wire...
Singapore: Australian biotechnology company Minomic is all set to launch two overseas trials of its MiStat prostate canc...
Singapore: According to a survey by Accenture, majority of Australian doctors (77 percent) have highlighted that sharing...
‎Singapore: ReSearch Pharmaceutical Services, a clinical research firm, has appointed Mr Marc Wolff as its chief f...
Singapore: Phylogica, a public Australian peptide drug discovery company, has achieved a research milestone under its co...
Singapore: Australian drug discovery and development company Alchemia has appointed Dr Susan Kelley and Mr Nathan Drona ...
Singapore: Patrys, a clinical stage biotechnology company, has received approval to progress its Phase I/IIa PAT-SM6 mul...
Australia-based Hatchtech, which was started in October 2001, is developing a new generation of low-toxicity ovacides fo...
Q: How do you look at the nano-biotech achievements in India so far? Have the applications been enough?Dr Pachauri: I th...
Singapore: Researchers from St Vincent's Institute of Medical Research in Melbourne, Australia, in collaboration with re...
Singapore: Universal Biosensors reported its unaudited financial result for FY 2012 including a doubling of total revenu...
Singapore: Pfizer has revealed that its phase III study of INLYTA (axitinib) did not meet the primary endpoint of demons...
Driving in the niche industry of sleep disorders, ResMed was aggressive in strengthening its portfolio through acquisiti...
Singapore: Drug and diagnostic company Agenix announced that it was on track to submit a new drug clinical trial applic...
Nanoparticles as a drug delivery system enables unique approaches for cancer treatment. Over the last two decades, a lar...
Singapore: Prima BioMed's interim data from the CAN-003 phase II clinical trial of cancer vaccine therapy, CVac, which ...
Singapore: Starpharma reported net cash outflows from operating and investing activities for the year ending June 30, 20...
Singapore: South Australian biotechnology company, GeneWorks, developed a new DNA barcoding technology for use as a secu...
Singapore: Australia based Bionomics is recognized as the Innovative Asian Biotech of the Year at BioPharma Asia Industr...
Singapore: Regenerative medicine company Mesoblast's phase II clinical trial for lumbar spinal fusion successfully met ...
Singapore: US-based Vertex Pharmaceuticals has received Therapeutic Goods Administration (TGA) of Australia approval of ...
Singapore: A team of Australian scientists discovered new genes that show identifiable changes in the blood of people wi...
Singapore: Algae.Tec, an Australian biofuels company, has appointed Mr Colin McGregor as general manager project operati...
Singapore: Phylogica has been granted a new European patent (no. 1793841) entitled: 'Peptide inhibitors of c-Jun dimeriz...
Singapore: Irish medtech firm Mainstay Medical has started its clinical trials on Implanted Reactiv8 unit that is being ...
Singapore: International investment bank, Canaccord Genuity, expanded its Australian operations with the addition of a ...
The research and development (R&D) spend in Asia Pacific in 2011 was down by 50 percent to an average of 6.58 percen...
Singapore: The board of Genetic Technologies (GTG) has appointed Ms Alison Mew as the permanent chief executive officer...
Singapore: The Australian Institute of Health and Welfare (AIHW) has presented a report that showed that though health c...
Lack of appropriate funding for early- to mid-stage innovation companies, limited local capital, local grants for small ...
‎Singapore: Australia-based CSL Behring achieved improved pharmacokinetic results for its novel investigational re...
Singapore: Living Cell Technologies has appointed Dr Paul Tan as its chief science and medical officer. As CSMO, Dr Tan...
Singapore: Mr Jackson Huang from the Queensland Academy of Science, Mathematics and Technology, has been named Australia...
Singapore: Allied Healthcare has achieved positive results in the study of Adapt-treated tissue as a bioprosthetic subst...
Singapore: Australia based Biotron's HIV drug candidate BIT225 has demonstrated its ability to reverse HIV-induced impai...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
The medical devices industry has progressed by leaps and bounds in the recent past and this is evident from the several ...
Singapore: Australia-based ResMed, a medical device company working on sleep-disordered breathing and respiratory condit...
Singapore: Researchers at the Burnet Institute have solved a hepatitis C vaccine mystery which, once developed, could b...
Singapore: GI Dynamics has entered into an agreement with CMS Medical, headquartered in Goiânia, Brazil, to distribut...
Singapore: In a blow to AstraZeneca, a multinational pharmaceutical company, the Federal Court of Australia has found t...
Singapore: A new Australian study led by Professor Susan Clark from Sydney's Garvan Institute of Medical Research shows ...
Singapore: Australian infectious disease therapy and vaccine development company BioDiem is developing an antimicrobial ...
We come across several women in the field of biotechnology at the graduation and post-graduation level of education. How...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
A better flu drug is on its way. This new class of specific, mechanism-based anti-influenza drug works by preventing the...
Singapore: Australian drug development company, Biotron, has commenced a landmark phase II human trial of its lead anti...
Food has been used as a pharmaceutical agent to treat diseases since time immemorial and the pharmaceutical use of food ...
Singapore: Adelaide-based company, Bioconst, commenced research on its second generation of fluorescent flowers using DN...
Singapore: Australia-based Allied Healthcare's ongoing phase II extension study for CardioCel, its lead regenerative tis...
Singapore: Australia biopharmaceutical firm CSL has signed an agreement to settle the US antitrust class action litigati...
Singapore: Cytori Therapeutics received notice from the Australian Therapeutic Goods Administration (TGA) that its Celut...
